Tulea Health partners with health systems to develop and establish freestanding ambulatory infusion centers. This service allows health systems to offer convenient, lower-cost sites of care while maintaining control over the patient experience. The company manages the capital investment and operational risk associated with launching these specialized infusion services.
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Health systems are losing infusion volume to for‑profit freestanding infusion providers that can offer lower‑cost, high‑convenience sites of care. At the same time, patients and payors increasingly demand accessible, cost‑effective outpatient infusion services, creating a gap between existing hospital‑based infusion capacity and market expectations.
Solution
Tulea Health partners with health systems to design, finance, and launch dedicated ambulatory infusion centers (AICs) that remain owned by the health system while Tulea assumes the capital outlay and operational risk. By leveraging a data‑driven market analysis, Tulea tailors each center’s layout, staffing model, and service mix to align with local patient demographics and payer contracts. The company provides end‑to‑end project management—including site acquisition, construction, equipment procurement, and regulatory compliance—so the health system can focus on clinical delivery and patient experience. Once operational, Tulea implements standardized clinical protocols, real‑time performance dashboards, and financial benchmarks to ensure cost containment and quality outcomes. This collaborative model enables health systems to recapture infusion volume, meet payer cost‑containment goals, and expand their outpatient portfolio without upfront capital commitments.
Target Audience
Primary customers are integrated health systems and hospital networks seeking to expand outpatient infusion capacity while minimizing capital risk and operational overhead. The solution also serves specialty clinics and oncology groups that require dedicated, cost‑effective infusion sites aligned with value‑based care contracts.
Features
- Full‑service capital financing and construction management for purpose‑built AIC facilities, eliminating upfront CapEx for the health system
- Risk‑transfer framework where Tulea assumes operational, clinical, and financial liabilities during launch and growth phases
- Integrated clinical workflow platform that syncs with existing EHR systems, supporting order entry, infusion scheduling, and outcome tracking
- Real‑time analytics suite delivering KPI dashboards on throughput, adverse events, and payer reimbursement performance
- Scalable staffing model with credentialed infusion nurses, pharmacy technicians, and on‑site care coordinators trained to health‑system standards
- Compliance package covering CMS, Joint Commission, and state pharmacy regulations, ensuring audit‑ready operations from day one
- Flexible lease‑to‑own arrangement allowing health‑system partners to retain ownership while gradually assuming operational control